Showing results (141-150 of 435) with videos related to
Sort By:
Pageof 44
Clinical Colorectal Cancer|February 19, 2008
Second-line chemotherapy use in metastatic colon cancer varies by disease responsivenessSeth Politano, Michael Overman, Priyanka Pathak, et al.Oncotarget|April 14, 2017
Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinomaZhimin Tong, Devkumar Chatterjee, Defeng Deng, et al.Plos One|October 22, 2013
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancerChristopher H Lieu, Hai Tran, Zhi-Qin Jiang, et al.Cell Reports|June 22, 2022
KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacyMeagan B Ryan, Oluwadara Coker, Alexey Sorokin, et al.Clinical Colorectal Cancer|April 28, 2012
Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experienceDavid S Hong, Jesal C Patel, Jennifer Wheler, et al.Biorxiv : the Preprint Server for Biology|March 10, 2025
IL-1R1 Blockade Boosts CD40 Agonist Immune Responses but Fails to Improve Efficacy or Reduce Hepatotoxicity in Pancreatic CancerAkash Boda, Irfan N Bandey, Saikat Chowdhury, et al.Cancer|November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 studyPat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.Molecular Cancer Research : MCR|November 1, 2024
Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer CellsAbigail J Clevenger, Claudia A Collier, John Paul M Gorley, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 18, 2020
Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver MetastasesYoshikuni Kawaguchi, Timothy E Newhook, Hop S Tran Cao, et al.Clinical Colorectal Cancer|July 30, 2014
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancerVan Morris, Michael J Overman, Zhi-Qin Jiang, et al.Pageof 44